![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://i1.rgstatic.net/ii/profile.image/767188256444417-1559923342070_Q64/Haluk-Yuzugullu.jpg)
PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://www.researchgate.net/publication/317157508/figure/fig2/AS:518699893624832@1500679099966/Presence-of-PIK3CA-mutations-confers-resistance-in-colony-forming-assays-and_Q320.jpg)
PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://i1.rgstatic.net/ii/profile.image/521949324300289-1501453824222_Q64/Jean-Zhao.jpg)
PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://i1.rgstatic.net/publication/317157508_PIK3CA_hotspot_mutations_differentially_impact_responses_to_MET_targeting_in_MET-driven_and_non-driven_preclinical_cancer_models/links/59728ac30f7e9b4016944858/largepreview.png)
PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://i1.rgstatic.net/ii/profile.image/1108668732968960-1641338632659_Q64/Gonzalo-Recondo-2.jpg)
PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models
![PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models PDF) PIK3CA hotspot mutations differentially impact responses to MET targeting in MET-driven and non-driven preclinical cancer models](https://www.researchgate.net/publication/317157508/figure/fig5/AS:668321846423554@1536351753554/Differential-effects-on-cell-proliferation-and-cell-death-of-single-and-dual-MET-PI3K_Q320.jpg)